Company: FEAV
Filing Date: 2025-05-23
Form Type: S-3
Source: 0001193125-25-125840
Chunk: 19

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-05-23
Form: S-3
Chunk 19
---
 are required to appoint or nominate such persons to our Board. Such party’s respective designation right will continue for so long as each such party beneficially owns 25% of our common stock, and one director to serve on the Company’s Board for so long as each such party beneficially owns 10% of our common stock, in each case including any shares of common stock previously issued or issuable to such party in connection with its exercise of the warrants issued to such party on March 13, 2025, and otherwise without regard to any of the limitations on exercise of such warrants. The size of our Board was also reduced to four directors pursuant to the terms of this agreement. 15

SELLING STOCKHOLDERS This prospectus relates to the offer and resale from time to time by the Selling Stockholders of up to 1,984,709 shares of common stock issued and sold to the Selling Stockholders pursuant to the Subscription Agreements for cash proceeds to the Company of $3.55 per share, and up to 37,042 shares of common stock issued to one of the Selling Stockholders as partial consideration for advisory services. The Selling Stockholders may from time to time offer and sell any or all of the Shares set forth below pursuant to this prospectus and any applicable prospectus supplement. When we refer to the “Selling Stockholders” in this prospectus, we mean the persons and entities listed in the table below, and the pledgee(s), donee(s), transferee(s), assignee(s), successor(s) and others who later come to hold any of the Selling Stockholders’ interest in our securities after the date of this prospectus. The following table sets forth, as of May 14, 2025, the names of the Selling Stockholders, the aggregate number of shares of common stock beneficially owned by the Selling Stockholders, the number of shares of common stock that may be sold by the Selling Stockholders under this prospectus and the number of shares of common stock that the Selling Stockholders will beneficially own after this offering. For purposes of the table below, we have assumed that after this offering, none of the shares of common stock covered by this prospectus will be beneficially owned by the Selling Stockholders. In addition, we assume that the Selling Stockholders have not sold, transferred or otherwise disposed of, our securities in transactions exempt from the registration requirements of the Securities Act. We cannot advise you as to whether the Selling Stockholders will sell any or all of such